Jennifer R. Brown, MD, PhD | Authors


Zanubrutinib/Venetoclax Shows Efficacy in High-Risk CLL Subgroup

January 05, 2022

Jennifer R. Brown, MD, PhD, discusses the interim results of the SEQUOIA trial , which investigated the combination of zanubrutinib and venetoclax for patients with treatment-naïve chronic lymphocytic leukemia or small lymphocytic lymphoma.

Unmet Needs in Frontline Treatment of CLL

March 29, 2021

The shortcomings physicians face in combatting CLL (chronic lymphocytic leukemia) are discussed, in addition to what the high-level updates from the ELEVATE-RR press release may reveal regarding future treatments for CLL.